Since the emergence of the new strain omicron in the United States, the vaccines are under continuous scrutiny by the medical experts in the country. They are asking tough questions from the vaccine developers regarding the effectiveness and efficiency of the vaccines to fight against the omicron variant as the inefficiency shown by the vaccines has made them ask such questions.
American Citizens Struck Between A Single Shot Of J&J & A Third Shot
Now as the pandemic emerged, the kind of vaccines that came also developed. Several pharmaceutical companies manufactured the COVID-19 vaccines and helped the people to prevent themselves from infection. Although Pfizer and Moderna have escaped the major debate by proving themselves to be better than their third rival Johnson & Johnson vaccine.
However, recently, talks around the Johnson and Johnson vaccine caught a spike when the people receiving its shots were said to have been developing symptoms of thrombosis and thrombocytopenia. The US Food and Drug Administration has put a hold on the Johnson & Johnson vaccine after the matter came through.
Also, the medical agency also suggested the American population rely less on the J&J vaccine and must go for the mRNA vaccines developed by Pfizer and Moderna.
The US FDA had given the approval to Johnson & Johnson’s second shot in the month of October for people aged 18 years and older. It must be noted that the second shot could be taken after 2 months of the first dose.
The Pfizer or Moderna’s booster shots have received the approval from Food and Drug Administration but no progress has been made regarding the production of J&J vaccines. This has kept the people in the alert zone and they have been stuck.
The Food and Drug Administration is now keen on collecting the data related to it and making some advancements for the recipients of the J&j vaccine. The focus is on collecting evidence and not taking decisions based on assumptions.
The coverage on the J&J vaccine has not been much and the focus has remained on Pfizer and Moderna vaccines more and the main reason is that the Administration authorized a third vaccine at least 3 months later and by the time the2 big vaccine developers grabbed the market share easily.
Right now, only a specific percentage of the population has received the primary series of vaccines and they are free to select the type of booster dose they want. Also, the data shared by the J&J during the clinical trials of mix and matching of vaccine shows that the booster shots developed by the J&J are very effective after the initial 2 doses of the Pfizer’s vaccine.
According to the medical agencies which are administering the vaccines and booster shots in the country have stated that even if you have received the Johnson & Johnson vaccine initially, you can opt for the Pfizer or Moderna booster shots after two months of being fully vaccinated and it is the eligibility criteria for the J&J.
